Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

The structural basis for monoclonal antibody 5D2 binding to the tryptophan-rich loop of lipoprotein lipase

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Chylomicronemia from GPIHBP1 autoantibodies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. ANGPTL4 inactivates lipoprotein lipase by catalyzing the irreversible unfolding of LPL's hydrolase domain

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Lipoprotein(a): the common, likely causal, yet elusive risk factor for cardiovascular disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Chylomicronemia from GPIHBP1 autoantibodies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Disorder in a two-domain neuronal Ca2+-binding protein regulates domain stability and dynamics using ligand mimicry

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Chylomicronemia From GPIHBP1 Autoantibodies Successfully Treated With Rituximab: A Case Report

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • John Luz
  • Anne P Beigneux
  • DeeAnn K Asamoto
  • Cuiwen He
  • Wenxin Song
  • Christopher M Allan
  • Jazmin E Morales
  • Yiping Tu
  • Adam Kwok
  • Thomas Cottle
  • Muthuraman Meiyappan
  • Loren G Fong
  • Judy Kim
  • Michael Ploug
  • Stephen G Young
  • Gabriel Birrane
Vis graf over relationer

For three decades, the lipoprotein lipase (LPL)-specific monoclonal antibody 5D2 has been used to investigate LPL structure/function and intravascular lipolysis. 5D2 has been used to measure LPL levels, block the triglyceride hydrolase activity of LPL, and prevent the propensity of concentrated LPL preparations to form homodimers. Two early studies on the location of the 5D2 epitope reached conflicting conclusions, but the more convincing report suggested that 5D2 binds to a tryptophan (Trp)-rich loop in the carboxyl terminus of LPL. The same loop had been implicated in lipoprotein binding. Using surface plasmon resonance, we showed that 5D2 binds with high affinity to a synthetic LPL peptide containing the Trp-rich loop of human (but not mouse) LPL. We also showed, by both fluorescence and ultraviolet resonance Raman spectroscopy, that the Trp-rich loop binds lipids. Finally, we used X-ray crystallography to solve the structure of the Trp-rich peptide bound to a 5D2 Fab fragment. The Trp-rich peptide contains a short alpha-helix, with two tryptophans projecting into the antigen recognition site. A proline substitution in the alpha-helix, found in mouse LPL, is expected to interfere with several hydrogen bonds, explaining why 5D2 cannot bind to mouse LPL.

OriginalsprogEngelsk
TidsskriftJournal of Lipid Research
ISSN0022-2275
DOI
StatusUdgivet - 20 jul. 2020

Bibliografisk note

Published under license by The American Society for Biochemistry and Molecular Biology, Inc.

ID: 60626901